| Literature DB >> 33914074 |
Hazrat Ismail1, Xu Liu1,2, Fengrui Yang1,2, Junying Li1,3, Ayesha Zahid1, Zhen Dou1, Xing Liu1,3, Xuebiao Yao1,3.
Abstract
Evolution has enabled living cells to adopt their structural and functional complexity by organizing intricate cellular compartments, such as membrane-bound and membraneless organelles (MLOs), for spatiotemporal catalysis of physiochemical reactions essential for cell plasticity control. Emerging evidence and view support the notion that MLOs are built by multivalent interactions of biomolecules via phase separation and transition mechanisms. In healthy cells, dynamic chemical modifications regulate MLO plasticity, and reversible phase separation is essential for cell homeostasis. Emerging evidence revealed that aberrant phase separation results in numerous neurodegenerative disorders, cancer, and other diseases. In this review, we provide molecular underpinnings on (i) mechanistic understanding of phase separation, (ii) unifying structural and mechanistic principles that underlie this phenomenon, (iii) various mechanisms that are used by cells for the regulation of phase separation, and (iv) emerging therapeutic and other applications.Entities:
Keywords: biomolecular condensates; intrinsically disordered proteins; liquid–liquid phase separation; membraneless organelles; post-translational modifications
Mesh:
Year: 2021 PMID: 33914074 PMCID: PMC8339361 DOI: 10.1093/jmcb/mjab028
Source DB: PubMed Journal: J Mol Cell Biol ISSN: 1759-4685 Impact factor: 6.216
Figure 1Schematic diagram and molecular basis for phase separation-driven assemblies. (A) Proteins that assemble to form MLOs contain different types of domains such as LCRs, oligomerization domains, folded binding domains. They create multivalency and thus offer a framework for establishing multivalent interactions, which bring molecules together and increase their local concentration. When the critical concentration threshold is reached, phase separation takes place. Many factors, such as appropriate PTMs and active transcription of component proteins, favor the nucleation reactions facilitating phase separation and stress signals whereas disfavor the multivalent interactions leading to complete or partial disassembly. (B) A phase diagram is constructed by varying protein concentrations and environmental/storage conditions. The solid red line is a function of environmental conditions such as pH, ionic strength, and temperature and differentiates between one-phase and two-phase regimes. A critical concentration threshold must be reached by the system to undergo phase separation. The system is in one mixed phase at C< Csat. Within two-phase regime, under any given conditions, the system demixes to form a light phase with C=CL and a dense phase with C=CD. Tie lines (purple) represent all the conditions that result in two-phase systems, with only fraction volume of two phases, fL and fD, fluctuating relative to each other as depicted in examples 2–4. During equilibrium, Csat and CL are equivalent; however, during nucleation of phase separation, they can vary. (C) Solid red line represents the binodal boundary at which molecules reach their solubility limit and demix from the surrounding solution. Dashed red line represents the spinodal curve where the system undergoes spinodal decomposition. In the area between binodal and spinodal curves, nucleation occurs and the system demixes (B and C were adapted from Alberti et al., 2019).
Figure 2Different modes of multivalent interactions driven by modular domains or IDRs in the system undergoing LLPS and different forces contributing to protein phase separation. (A) Proteins containing IDRs such as DDX4 establish cation–π interactions between aromatic amino acids and positively charged basic residues. (B) In C-terminal domain of TDP-43, an evolutionary conserved, short helical segment forms intermolecular helical interaction necessary for phase separation. (C) Nephrin contains three pTyr motifs (red), which interact with the SH2 domain (purple) of Nck. Nck has three SH3 domains (yellow), which bind to the numerous PRMs (green) in N-WASP. (D) Schematic interaction network of presynaptic active-zone proteins RIM and RIM-BP together with the cytoplasmic tail of NCav. Interactions between PRMs of RIM and SH3 domains of RIM-BP drive system’s co-clustering that lowers the threshold concentration required to carry out phase separation and also accounts for tight coupling of Ca2+ influx and neurotransmitter release in presynaptic zone. (E) NPM1 assembles into pentamers via its oligomerizing domain (blue) and binds to proteins that contain positively charged arginine-rich linear motifs (R-motifs) (green) through its negatively charged acidic tracts (yellow). (F) EDC3 dimerizes via its YJeF amino-terminal domain (sky blue) and binds to the helical leucine-rich motifs (pink) in DCP2 via its LSm domain (orange). (G) Proteins undergoing LLPS utilize various types of interactions including cation–π, π–π, charge–charge, hydrophobic, and transient cross-β-contacts.
Figure 3Compositional control model for PTMs on phase separation. (A) Multivalent molecules forming the scaffold of the condensates contain complementary modules that facilitate the assembly of the scaffold resulting in phase-separated condensates shown by yellow structures. Client molecules in this example possess interaction domains that are complementary to the scaffold components and are recruited to the condensates by binding to the complementary sites but at a lower valency. (1) Scaffold component having green modules is present in stoichiometric excess yielding free green scaffold sites. Clients having red modules can be recruited to the condensate by binding to the green scaffold sites that are unbound. (2) Scaffold component having red modules is present in stoichiometric excess yielding free red scaffold sites. Clients containing blue modules can be recruited to the condensate by binding to the red scaffold sites that are unbound. (3) Higher valency of the blue client promotes stronger recruitment of this client when the red scaffold module is in stoichiometric excess (Banani et al., 2016). (B) Color code represents the respective PTM. Under in vitro conditions, various LCDs, RBPs, or IDRs are modified by PTMs that either enhance or suppress their phase-separating behaviors. (C) The composition, assembly, or disassembly of various biological condensates such as Balbiani body (Bb), P-body (PB), stress granules (SG), and amyloid-like aggregates is regulated by PTMs in vivo. An arrow pointing up depicts promotion of phase separation upon the respective PTM, and an arrow pointing down depicts suppression of phase separation by the respective PTM.
Phase separation plays important roles in a variety of critical cellular processes.
| Function | Description | References |
|---|---|---|
| Cellular sensing | Various biological condensates can sense the variations in temperature, pH, or other stress signals. |
|
| Buffering cellular protein concentrations | Excess protein is stored in MLOs and will enter the dilute phase as required when needed. |
|
| Immunity | Many signaling components involved in innate immune pathways are capable of oligomerization to form higher-order assemblies. |
|
| Cellular signaling | Condensate formation serves as a conserved signal transduction mechanism in innate immunity and inflammation. |
|
| Sequestration | Molecular condensation functions to sequester factors not required for cellular needs and thereby prevents off-target effects. |
|
| Mediating localization of proteins to pre-existing MLOs | Phase separation can mediate targeting of molecules to pre-existing organelles, as has recently been proposed for ubiquilin 2 and SPOP. |
|
| Force generation | The energy of multivalent molecular interactions that drive phase separation is utilized to alter the macroscopic structural features of other biomolecular assemblies. |
|
| Formation of physicochemical and mechanical filters | The number and dynamics of the cross-links between the macromolecules that make up the condensate determine the size of pores that serve as filters that allow exchange of specific molecules, e.g. nuclear pores. |
|
| Reaction crucible | Phase separation concentrates a specific set of molecules into the condensed state that facilitates efficient cellular reactions between weakly interacting molecules. |
|
| Regulating the specificity of biochemical reactions | Phase-separated compartments could concentrate a protein with a subset of its potential interacting partners while excluding others, imparting specificity to biochemical processes. |
|
| Compartmentalization without physical barriers | Phase separation allows the organization of biomacromolecules spontaneously to form different subcellular compartments without the help of lipid membranes. |
|
| Direct communications between MLOs and membrane organelles | MLOs can communicate with membrane-bound organelles via direct interactions. |
|
| Organizational hub | LLPS and the resulting condensates appear to be exploited by cells to organize their internal space. |
|
| Skin barrier formation | Epidermal structure and functions are driven by phase-separation dynamics. |
|
| Reduction of noise in cells | Compartmentalization of proteins through phase separation has been suggested as a potential mechanism to reduce noise in the cell. |
|
| Gene regulation | Many components involved in gene regulation form dynamic protein assemblies that contribute to their regulatory mechanisms. |
|
| Cell fate decision | MLOs such as nucleoli, centrosomes, heterochromatin, and centromeres confer cellular plasticity and contribute to cell fate decision. |
|
| Evolution | Compartmentalization mediated by phase separation reveals how proteins and nucleic acids assemble into condensed bioreactors in the ocean before the emergence of lipid membranes. |
|
| Synapse formation and signal transduction | Formation and activity-dependent modulation of PSDs is considered as one of the most basic molecular events governing synaptic plasticity in the nervous system. Phase separation has been reported to play significant roles in the formation of PSDs via condensation of scaffold protein/neurotransmitter receptor complexes. |
|
| Establishment of cell polarity | The Par complex exhibits cell cycle-dependent condensation in |
|
| Enzyme or complex-mediated signal transduction | Formation of modular enzyme complex condensates through phase separation can dynamically concentrate enzymes to specific cellular compartments for optimal signaling. |
|
Diseases linked with aberrant phase separation and potential treatment strategies.
| Disease | Contribution of phase separation in disease | Potential treatment strategies | References |
|---|---|---|---|
| ALS |
Mutations in TDP-43, FUS, hnRNPA1, hnRNPA2, and TIA-1 promote aberrant phase separation and pathological aggregation of the respective protein in stress granules. Abnormal PTMs on RBPs are associated with pathological phase transitions in ALS. |
Knockdown of Ataxin-2 in mouse model of ALS through ASOs was shown to lower the TDP-43 aggregates in the spinal cord of ALS mouse models. Engineered Hsp104 variants have been shown to disassemble ALS-associated FUS aggregates in mammalian cells. Enhancing the selective targeting of misfolded proteins to autophagy can enhance their localization and clearance. |
|
| AD | Disease-linked Tau mutations or aberrant PTMs promote condensed phase and subsequent hardening and aggregation of proteins involved in AD pathology. | TIA-1 knockdown through ASOs prevented Tau pathology in neuronal culture and rodent models. |
|
| Huntington disease (HD) | Poly-glutamine (polyQ) aggregates are formed due to anomalous phase separation in HD. Many of these proteinaceous assemblies can spread from one brain region to another. | Profilin, the product of the PFN1 ALS-associated gene, binds to the monomeric phase of polyQ Huntington protein preferably and suppresses LLPS and pathogenic fibrillar aggregation |
|
| FTD |
DIease-causing mutations of TDP-43 or FUS along with polyadenylate-binding protein 1, eukaryotic translation initiation factor 4 gamma 1, and TIA-1 cause abnormal phase separation. Abnormal PTMs on RBPs are associated with pathological phase transitions in FTD. | Disease-related PTM enzymes that alter client partition into condensates can be potential targets. |
|
| Parkinson’s disease (PD) | The phase transition of α-Synuclein from a monomeric to oligomeric state and further to fibrils is related to the pathological toxicity of PD. | Use of specific chaperone variants can disassemble aberrant protein aggregates, e.g. use of Hsp104 variant in |
|
| Cancer | Cancer mutations promote the formation of anomalous signaling clusters having abnormal composition, which activate downstream oncogenic signaling events. |
LLPS inhibitor, 1,6-hexanediol significantly inhibited cell proliferation and induced cell death in all tested pancreatic cancer cells (BxPC-3, PANC-1, AsPC-1, and CFPAC-1). A potential therapeutic strategy for the treatment of tight junction-associated diseases such as tumor invasion and metastasis is the targeting of phase separation by ASOs based on the known actions of miRNAs. |
|
| Trinucleotide repeat disorder | Due to repetitive number of nucleotide repeats within the gene, such sequences can engage in multivalent intermolecular interactions and thus form condensates by phase separation. |
| |
| Infectious diseases | Many viruses induce the formation of compartments termed as viral factories, viroplasm, or viral replication centers upon infection of their host cell via LLPS. These compartments promote the production of virus components and allow viruses to evade the immune system, e.g. Measles virus nucleo- and phosphoproteins form phase-separated compartments that promote nucleocapsid assembly. | LLPS is essential for viral assembly for many viruses such as SARS-CoV-2, which hints for developing intervention strategies by disrupting LLPS and viral assembly. |
|
| Primary biliary cirrhosis | Arg-methylation of RNA-associated protein 55A reduces its phase separation in stress granules and P-bodies, which contributes to disease pathology. | Disease-related PTM enzymes that alter client partition into condensates can be potential targets. |
|
| Fragile X Syndrome | Aberrant Ser/Tyr phosphorylation enhances the phase separation of C-terminal LCD region of fragile X mental retardation protein, which contributes to disease condition. | Disease-related PTM enzymes that alter client partition into condensates can be conventional targets for small-molecule drugs. |
|